NetworkNewsBreaks – SeeThruEquity Updates Coverage, Increases PT on Medical Transcription Billing, Corp. (NASDAQ: MTBC)
SeeThruEquity has updated its coverage and increased its price target to $4 on shares of Medical Transcription Billing, Corp.’s (NASDAQ: MTBC) stock. The company recently reported financial results for the second quarter of 2017, including a 49% increase in revenues, year-over-year. MTBC also reported a 55% increase for the first half of 2017, with revenues of approximately $16 million. The company attributes this growth primarily to its largest acquisition, MediGain, and a higher rate of retention from MediGain customers than originally expected. For more information, visit www.mtbc.com About Medical Transcription Billing, Corp. MTBC is a healthcare information technology company that…







